title: Role of imidazoline receptors in cardiovascular regulation.
abstract: The involvement of nonadrenergic imidazoline specific receptors in the central control of the vasomotor tone and in the mechanism of action of drugs bearing an imidazoline structure, or analogs, is now well documented. Imidazoline-specific binding sites were found in many tissues and species. Moreover, until now, it is only in the brainstem that such binding sites are associated with a function: the hypotensive effect of imidazoline-like drugs. Rilmenidine, which is an oxazoline structurally related to the reference imidazolines, exerts a central hypotensive effect of central origin involving imidazoline receptors. The selectivity of rilmenidine for the imidazoline receptors compared to alpha 2-adrenergic receptors could explain the low incidence of sedative side effects observed with this antihypertensive drug. A specific anti-imidazoline radioimmunoassay allowed us to detect the presence of an immunoreactive imidazoline-like substance in human sera. High levels of this immunoreactive substance are associated with high blood pressure in 20-30% of the hypertensive patients. This observation indicates that high levels of this immunoreactive substance in the serum can be associated with some kinds of primary hypertension. The cause-and-effect relation between these 2 phenomena has not yet been determined. This substance is in process of purification; it could be a candidate to be an endogenous ligand of the imidazoline receptors.
authors.affiliation: Laboratoire de Pharmacologie Cardiovasculaire et Rénale, CNRS URA 589, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France.
authors.forename: M
authors.initials: M
authors.lastname: Dontenwill
authors.forename: E
authors.initials: E
authors.lastname: Tibiriça
authors.forename: H
authors.initials: H
authors.lastname: Greney
authors.forename: F
authors.initials: F
authors.lastname: Bennaï
authors.forename: J
authors.initials: J
authors.lastname: Feldman
authors.forename: J
authors.initials: J
authors.lastname: Stutzmann
authors.forename: G
authors.initials: G
authors.lastname: Bricca
authors.forename: A
authors.initials: A
authors.lastname: Belcourt
authors.forename: P
authors.initials: P
authors.lastname: Bousquet
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002320:Cardiovascular Physiological Phenomena; D006801:Humans; D006973:Hypertension / Q000097:blood; D007093:Imidazoles / Q000276:immunology / Q000378:metabolism*; D054755:Imidazoline Receptors; D011955:Receptors, Drug / Q000276:immunology / Q000502:physiology*; D014666:Vasomotor System / Q000378:metabolism / Q000503:physiopathology
chemical_list: D007093:Imidazoles; D054755:Imidazoline Receptors; D011955:Receptors, Drug